[
  {
    "ts": null,
    "headline": "Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds",
    "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in the […]",
    "url": "https://finnhub.io/api/news?id=e9ea8d47a9be3a7d2c3a3beabb0d63020d6a625855feae50fd29013e244e9ed3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741804652,
      "headline": "Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds",
      "id": 133184486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in the […]",
      "url": "https://finnhub.io/api/news?id=e9ea8d47a9be3a7d2c3a3beabb0d63020d6a625855feae50fd29013e244e9ed3"
    }
  },
  {
    "ts": null,
    "headline": "Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%",
    "summary": "Roche inked a new deal in the obesity space, giving Novo Nordisk more competition in its own backyard.",
    "url": "https://finnhub.io/api/news?id=373621ca998c4ab5bd2833ce670a4183edd9d4024f9f62e3f025d34d62b4c96e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741795343,
      "headline": "Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%",
      "id": 133184283,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Roche inked a new deal in the obesity space, giving Novo Nordisk more competition in its own backyard.",
      "url": "https://finnhub.io/api/news?id=373621ca998c4ab5bd2833ce670a4183edd9d4024f9f62e3f025d34d62b4c96e"
    }
  },
  {
    "ts": null,
    "headline": "Caterpillar: Diversification Without Diworsification; Home Depot Looks Healthy, So Do Others",
    "summary": "Diversify Caterpillar holdings with tax-efficient strategies. Explore HD, LOW, and SNA for income replacement potential and strong dividend growth.",
    "url": "https://finnhub.io/api/news?id=9cf9ca56103d930886a81f4fb47de06448e6f9ac30502d33ccf692493d220c13",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741786147,
      "headline": "Caterpillar: Diversification Without Diworsification; Home Depot Looks Healthy, So Do Others",
      "id": 133156626,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2033001899/image_2033001899.jpg?io=getty-c-w750",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Diversify Caterpillar holdings with tax-efficient strategies. Explore HD, LOW, and SNA for income replacement potential and strong dividend growth.",
      "url": "https://finnhub.io/api/news?id=9cf9ca56103d930886a81f4fb47de06448e6f9ac30502d33ccf692493d220c13"
    }
  },
  {
    "ts": null,
    "headline": "VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply",
    "summary": "The deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its obesity drug VK2735.",
    "url": "https://finnhub.io/api/news?id=aec37e2dcfa275a84de49cbbaec77e915c0c89263bea7a84053225ca2f18ff60",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741781880,
      "headline": "VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply",
      "id": 133184488,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its obesity drug VK2735.",
      "url": "https://finnhub.io/api/news?id=aec37e2dcfa275a84de49cbbaec77e915c0c89263bea7a84053225ca2f18ff60"
    }
  },
  {
    "ts": null,
    "headline": "Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.",
    "summary": "One way is to own rock-solid dividend stocks that provide reliable income and less volatility than high-flying growth and tech stocks.  Real estate investment trusts (REITs) are terrific vehicles for income-focused investors.  REITs are also a way for investors to own real estate and collect rent without the complications and expense of buying real estate directly.",
    "url": "https://finnhub.io/api/news?id=ce4c8708803e399d177277bfa04cdec35d65ecff0688a59185fe3d336a338052",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741777800,
      "headline": "Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.",
      "id": 133184489,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "One way is to own rock-solid dividend stocks that provide reliable income and less volatility than high-flying growth and tech stocks.  Real estate investment trusts (REITs) are terrific vehicles for income-focused investors.  REITs are also a way for investors to own real estate and collect rent without the complications and expense of buying real estate directly.",
      "url": "https://finnhub.io/api/news?id=ce4c8708803e399d177277bfa04cdec35d65ecff0688a59185fe3d336a338052"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Select Health Care Portfolio Q4 2024 Review",
    "summary": "Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500Â® index.",
    "url": "https://finnhub.io/api/news?id=0d949fbfb9bc6d781dd942fc4d702b6a460558e2a5372e95abd05eb5e16657ae",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741773660,
      "headline": "Fidelity Select Health Care Portfolio Q4 2024 Review",
      "id": 133149109,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183355336/image_183355336.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500Â® index.",
      "url": "https://finnhub.io/api/news?id=0d949fbfb9bc6d781dd942fc4d702b6a460558e2a5372e95abd05eb5e16657ae"
    }
  }
]